Skip to main content

Nonprofit · EIN 23-7244966

INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE

Tax-exempt · SYRACUSE, NY 13215

Financials

$475K$486K2023$594K$651K2024
Revenue Expenses · by fiscal year end
Financials of INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$593,731$651,223-$57,492$786,507$5,396$781,111
December 31, 2023990$474,522$486,144-$11,622$839,573$992$838,581
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$110,537
Membership dues
$109,967
Program service revenue
$447,086
Investment income
$8,888
Other revenue
$27,220

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$146,080
Other salaries and wages
$6,841
Salaries, compensation and benefits (total)
$180,524
Professional fundraising fees
$0
Legal fees
$11,020
Accounting fees
$1,600
Depreciation
$585
Program services (functional)
$586,104
Management and general (functional)
$65,119

Balance sheet and other

Total assets, start of year
$839,573
Total assets, end of year
$786,507
Total liabilities, end of year
$5,396
Net assets, end of year
$781,111
Land, buildings and equipment
$2,542
Net assets without donor restrictions
$781,111
Gross receipts
$593,731
Employees
2
Volunteers
10
Year formed
1971
State of legal domicile
NC

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
Debbie RoepeExecutive Dir.
Officer
60$130,175$15,905
Debra HellerPresident
Trustee or director, Officer
10$0$0
Tanja BohlPast President
Trustee or director
0$0$0
Pedro V BaptistaPresident Elect
Trustee or director
5$0$0
Aruna VenkatesanSecretary Gener
Trustee or director, Officer
5$0$0
Jill AllbrittonBoard member
Trustee or director
1$0$0
Mitchell Berger MDTreasurer
Trustee or director, Officer
1$0$0
Amanda SelkBoard member
Trustee or director
1$0$0
Annemarie DixeBoard member
Trustee or director
1$0$0
Eleonora PretiBoard member
Trustee or director
1$0$0
Anne SammarcoAsst. Treasurer
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 10 people
NameTitleHours / weekCompensationOther / benefits
Debbie RoepeExecutive Dir.
Officer
60$113,683$9,210
Tanja Bohl MDPresident
Trustee or director, Officer
1$0$0
Colleen Stockdale MD MSPast President
Trustee or director
1$0$0
Debra Heller MDPresident Elect
Trustee or director
1$0$0
Pedro BaptistaSecretary Gener
Trustee or director, Officer
10$0$0
Jill AllbrittonBoard member
Trustee or director
1$0$0
Mitchell Berger MDTreasurer
Trustee or director, Officer
1$0$0
Jason ReutterBoard member
Trustee or director
1$0$0
Aruna VenkatesanBoard member
Trustee or director
1$0$0
Eleonora PretiBoard member
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
PO BOX 15112, SYRACUSE, NY 13215-0112
Principal officer (990 for 2024)
Debbie Roepe, PO Box 586, Waxhaw, NC 28173
Signed the 990
Debbie Roepe, Executive Dir.
Phone
(704) 709-3511
Return prepared by
Foard and Company PA

Mission

To promote international communication and education among gynecologists, pathologists, dermatologists, and and other healthcare providers, and to establish agreement on terminology and definitions of vulvovaginal diseases. To promote clinical investigation, basic research, and dissemination of knowledge in this field.

990 for the year ended December 31, 2024

Program accomplishments

  • The ISSVD Continuing Medical Education program supports the mission of the ISSVD to advance womens health through life-long education of its members.Goals1.To promote clinical investigation, basic research, and dissemination of knowledge in this field.2.To promote international communication among gynecologists, pathologists, dermatologists, and related disciplines, and to establish international agreement on terminology and definitions of vulvovaginal diseases.3.To facilitate improvement in womens health care outcomes with a diverse, evidence-based and comprehensive selection of educational opportunities.4.To support life-long learning through a continuing medical education program developed and directed to address clinical practice gaps and other learning needs identified nationally, locally, or individually.5.The expected results of the CME program is that learners will be able to: -gain and apply knowledge about important womens health issues -use the tools and skills provided during the CME activity to make a meaningful, positive impact in the health of women and -make a commitment to change behavior or practice as a result of participating in the CME activityVulvovaginal disease is not taught formally in medical schools or any other educational program. Therefore there are many practice gaps in the diagnosis and management of women suffering from the various vulvovaginal diseases that affect 8-15% of women at some point in their life. Research supports that 8-15% of women will suffer from vulvar pain lasting at least 6 months sometime in their lifetime. Many primary care providers and womens health practitioners incorrectly diagnose vulvar pain disorders.Many healthcare professionals demonstrate a lack of awareness about the various options for diagnosing and treating the varied symptoms that affect their female patients. Differences among terminology between countries increases the likelihood of misdiagnosis and treatment. Through the educational programs offered by ISSVD, we aim to increase the following: Knowledge: being aware of what to doCompetence: being able to apply knowledge, skills, and judgment in practice (knowing how to do something)Performance: having the ability to implement the strategy or skill (what one actually does)And to: -Give participants new abilities/strategies (change competence).-Help participants modify their practice (change performance).-Help improve patient outcomes.After identifying the practice gaps and educational needs, we will identify what we want the learner to be able to accomplish after the activity and produce learning objectives.
    Expenses $586,104

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
23-7244966
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1973
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$786,507
Income (IRS master file)
$593,731

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$593,731$651,223$786,507XML
990December 2023$474,522$486,144$839,573XML
990December 2022$578,378$567,905$852,236IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 23-7244966).

Questions about INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE

What is the EIN of INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE?
The employer identification number (EIN) of INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE is 23-7244966.
Is INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1973.
Are donations to INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE?
The 990 for the year ended December 31, 2024 names Debbie Roepe.
Who are the officers and directors of INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE?
The 990 for the year ended December 31, 2024 lists 11 people; 1 received compensation from the organization, the highest $130,175 (Debbie Roepe, Executive Dir.).
How much revenue does INTERNATIONAL SOCIETY FOR THE STUDY OF VULVOVAGINAL DISEASE have?
On its 990 for the year ended December 31, 2024 it reported revenue of $593,731, expenses of $651,223 and total assets of $786,507 at year end.

Other nonprofits in SYRACUSE

All nonprofits in SYRACUSE · New York